Edition:
Deutschland

Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

44.06EUR
23 Aug 2019
Change (% chg)

€0.06 (+0.15%)
Prev Close
€43.99
Open
€44.13
Day's High
€45.06
Day's Low
€43.99
Volume
1,937,925
Avg. Vol
1,740,278
52-wk High
€69.90
52-wk Low
€38.28

About

Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes... (more)

Buy/Sell

Sell Hold Buy
2.04 Mean rating from 24 analysts

Overall

Beta: 0.56
Market Cap(Mil.): €39,028.29
Shares Outstanding(Mil.): 554.54
Dividend: 0.62
Yield (%): 0.88

UPDATE 4-Fresenius slides as weakness in dialysis unit offsets improved outlook

* Fresenius expects FY 4%-7% revenue growth at constant currency

Fresenius raises full-year outlook after Q2 meets expectations

July 30 German healthcare group Fresenius raised full-year revenue targets on Tuesday as its adjusted second-quarter sales came in a touch above analysts' expectations.

CORRECTED-German stocks - Factors to watch on July 17

BERLIN/FRANKFURT, July 17 The following are some of the factors that may move German stocks on Wednesday:

German stocks - Factors to watch on July 1

BERLIN/FRANKFURT, July 1 The following are some of the factors that may move German stocks on Monday:

UPDATE 3-Akorn gets FDA warning letter for another manufacturing plant

June 25 Akorn Inc said on Tuesday it received a warning letter from the U.S. Food and Drug Administration regarding its manufacturing facility in New Jersey, the latest in a string of setbacks for the generic drugmaker.

Photo

Will Europe's clampdown on faulty medical devices hurt patients?

BERLIN When a Californian company founded by a U.S. veteran wounded in Afghanistan sought to register a new medical device this year, it turned to Europe before the United States. The European approvals system had long been quicker, the company said, but the introduction of new rules is changing all that.

Photo

Will Europe's clampdown on faulty medical devices hurt patients?

BERLIN When a Californian company founded by a U.S. veteran wounded in Afghanistan sought to register a new medical device this year, it turned to Europe before the United States. The European approvals system had long been quicker, the company said, but the introduction of new rules is changing all that.

INSIGHT-Will Europe's clampdown on faulty medical devices hurt patients?

* Stricter EU rules for medical products kick in from May 2020

Fresenius says tighter EU rules could trigger antibiotic shortage

* Regulator EMA working on revision of manufacturing guidelines

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie -0.78%
Rohstoffe -1.40%
Industrie -1.79%
Konjunktur abhängige Waren & Dienstleistungen -0.93%
Konjunktur unabhängige Waren & Dienstleistungen -1.61%
Finanzindustrie -1.75%
Pharma -2.78%
Technologie -0.90%
Telekommunikation -0.70%